These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction. Ernst NM; Suryapranata H; Miedema K; Slingerland RJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; de Boer MJ; Zijlstra F; van 't Hof AW J Am Coll Cardiol; 2004 Sep; 44(6):1187-93. PubMed ID: 15364318 [TBL] [Abstract][Full Text] [Related]
5. Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Akerblom A; James SK; Koutouzis M; Lagerqvist B; Stenestrand U; Svennblad B; Oldgren J J Am Coll Cardiol; 2010 Aug; 56(6):470-5. PubMed ID: 20670756 [TBL] [Abstract][Full Text] [Related]
6. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E; Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099 [TBL] [Abstract][Full Text] [Related]
7. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Armstrong PW; Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes. Collet JP; Montalescot G; Golmard JL; Tanguy ML; Ankri A; Choussat R; Beygui F; Drobinski G; Vignolles N; Thomas D Am Heart J; 2004 Apr; 147(4):655-61. PubMed ID: 15077081 [TBL] [Abstract][Full Text] [Related]
9. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G; Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313 [TBL] [Abstract][Full Text] [Related]
10. A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention. Choussat R; Montalescot G; Collet JP; Vicaut E; Ankri A; Gallois V; Drobinski G; Sotirov I; Thomas D J Am Coll Cardiol; 2002 Dec; 40(11):1943-50. PubMed ID: 12475453 [TBL] [Abstract][Full Text] [Related]
11. Prehospital administration of enoxaparin before primary angioplasty for ST-elevation acute myocardial infarction. Labèque JN; Jaïs C; Dubos O; Denard M; Berhouet M; Leroux L; Laplace G; Vergnes C; Pradeau C; Thicoïpe M; Dos Santos P; Coste P Catheter Cardiovasc Interv; 2006 Feb; 67(2):207-13. PubMed ID: 16416473 [TBL] [Abstract][Full Text] [Related]
12. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study. Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Gaudreault V; Proulx G; Barbeau G; Déry JP; Gleeton O; Manh-Nguyen C; Noël B; Roy L; Costerousse O; De Larochellière R; Am J Cardiol; 2010 Jun; 105(11):1520-7. PubMed ID: 20494655 [TBL] [Abstract][Full Text] [Related]
13. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction. Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565 [TBL] [Abstract][Full Text] [Related]
16. Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial). Madan M; Radhakrishnan S; Reis M; Paradiso-Hardy FL; Godin-Edgecombe M; Sparling C; Phillips AM; Shanmugasegaram S; Fort S; Naqvi SZ; Cohen EA Am J Cardiol; 2005 Jun; 95(11):1295-301. PubMed ID: 15904632 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of low-dose intravenous enoxaparin and GP IIb/IIIa inhibitor therapy during PCI. Carnendran L; Borkowski R; Markabawi B; Warner MF J Invasive Cardiol; 2003 May; 15(5):235-8. PubMed ID: 12730628 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy. Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921 [TBL] [Abstract][Full Text] [Related]
19. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program. Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182 [TBL] [Abstract][Full Text] [Related]
20. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. Kastrati A; Mehilli J; Neumann FJ; Dotzer F; ten Berg J; Bollwein H; Graf I; Ibrahim M; Pache J; Seyfarth M; Schühlen H; Dirschinger J; Berger PB; Schömig A; JAMA; 2006 Apr; 295(13):1531-8. PubMed ID: 16533938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]